These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1835967)

  • 1. Detailed toxicity studies of liposomal gadolinium-DTPA.
    Fritz T; Unger E; Wilson-Sanders S; Ahkong QF; Tilcock C
    Invest Radiol; 1991 Nov; 26(11):960-8. PubMed ID: 1835967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biodistribution and clearance of liposomal gadolinium-DTPA.
    Unger E; Cardenas D; Zerella A; Fajardo LL; Tilcock C
    Invest Radiol; 1990 Jun; 25(6):638-44. PubMed ID: 2354925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liposomal Gd-DTPA: effect of encapsulation on enhancement of hepatoma model by MRI.
    Unger EC; MacDougall P; Cullis P; Tilcock C
    Magn Reson Imaging; 1989; 7(4):417-23. PubMed ID: 2811620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mannan-coated liposome delivery of gadolinium-diethylenetriaminepentaacetic acid, a contrast agent for use in magnetic resonance imaging.
    Kunimasa J; Inui K; Hori R; Kawamura Y; Endo K
    Chem Pharm Bull (Tokyo); 1992 Sep; 40(9):2565-7. PubMed ID: 1446380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic metastases: liposomal Gd-DTPA-enhanced MR imaging.
    Unger EC; Winokur T; MacDougall P; Rosenblum J; Clair M; Gatenby R; Tilcock C
    Radiology; 1989 Apr; 171(1):81-5. PubMed ID: 2928550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liposomal Gd-DTPA: preparation and characterization of relaxivity.
    Tilcock C; Unger E; Cullis P; MacDougall P
    Radiology; 1989 Apr; 171(1):77-80. PubMed ID: 2928549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A comparative study between Gd-BOPTA, a biliary excretion contrast medium, and Gd-DTPA in the magnetic resonance imaging of the rat liver].
    Patrizio G; Pavone P; Cardone G; Pietroletti R; Passariello R; Tettamanti E; Musu C; Felder E
    Radiol Med; 1990 May; 79(5):458-62. PubMed ID: 2359853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo characterization of Gd(BME-DTTA), a myocardial MRI contrast agent: tissue distribution of its MRI intensity enhancement, and its effect on heart function.
    Chu WJ; Simor T; Elgavish GA
    NMR Biomed; 1997 Apr; 10(2):87-92. PubMed ID: 9267866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An improved method for the preparation of liposomal gadolinium-DTPA. Ionophore-mediated active entrapment of gadolinium.
    Tilcock CP; Ahkong QF; Parr M
    Invest Radiol; 1991 Mar; 26(3):242-7. PubMed ID: 2055729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gadolinium-labeled liposomes containing various amphiphilic Gd-DTPA derivatives: targeted MRI contrast enhancement agents for the liver.
    Kabalka GW; Davis MA; Moss TH; Buonocore E; Hubner K; Holmberg E; Maruyama K; Huang L
    Magn Reson Med; 1991 Jun; 19(2):406-15. PubMed ID: 1881329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gadolinium-DTPA liposomes as a potential MRI contrast agent. Work in progress.
    Unger E; Needleman P; Cullis P; Tilcock C
    Invest Radiol; 1988 Dec; 23(12):928-32. PubMed ID: 3203995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system.
    Schuhmann-Giampieri G; Schmitt-Willich H; Press WR; Negishi C; Weinmann HJ; Speck U
    Radiology; 1992 Apr; 183(1):59-64. PubMed ID: 1549695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Gd-BOPTA with Gd-DTPA in MR imaging of rat liver.
    Pavone P; Patrizio G; Buoni C; Tettamanti E; Passariello R; Musu C; Tirone P; Felder E
    Radiology; 1990 Jul; 176(1):61-4. PubMed ID: 2353112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gadolinium-labeled liposomes containing amphiphilic Gd-DTPA derivatives of varying chain length: targeted MRI contrast enhancement agents for the liver.
    Kabalka GW; Davis MA; Holmberg E; Maruyama K; Huang L
    Magn Reson Imaging; 1991; 9(3):373-7. PubMed ID: 1881256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clearance of liposomal gadolinium: in vivo decomplexation.
    Unger EC; Fritz TA; Tilcock C; New TE
    J Magn Reson Imaging; 1991; 1(6):689-93. PubMed ID: 1823174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The functional effects of gadolinium-DTPA on the isolated perfused rat kidney.
    Brown PW; Haylor JL; Morcos SK; el Nahas AM
    Eur J Radiol; 1993 Feb; 16(2):85-9. PubMed ID: 8462585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The synthesis and evaluation of macrocyclic gadolinium-DTPA-bis(amide) complexes as magnetic resonance imaging contrast agents.
    Varadarajan JA; Crofts SP; Carvalho JF; Fellmann JD; Kim SH; Chang CA; Watson AD
    Invest Radiol; 1994 Jun; 29 Suppl 2():S18-20. PubMed ID: 7928223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between thermodynamics and the toxicity of gadolinium complexes.
    Cacheris WP; Quay SC; Rocklage SM
    Magn Reson Imaging; 1990; 8(4):467-81. PubMed ID: 2118207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Entrapment of gadolinium-DTPA in liposomes. Characterization of vesicles by P-31 NMR spectroscopy.
    Devoisselle JM; Vion-Dury J; Galons JP; Confort-Gouny S; Coustaut D; Canioni P; Cozzone PJ
    Invest Radiol; 1988 Oct; 23(10):719-24. PubMed ID: 3192394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liposome-mediated delivery of gadolinium-diethylenetriaminopentaacetic acid to hepatic cells: a P-31 NMR study.
    Vion-Dury J; Masson S; Devoisselle JM; Sciaky M; Desmoulin F; Confort-Gouny S; Coustaut D; Cozzone PJ
    J Pharmacol Exp Ther; 1989 Sep; 250(3):1113-8. PubMed ID: 2778711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.